Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Three Distinct Groups of Phenotype Severity in Beta-Thalassemia

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-139196

Published: 2020

Journal Articles

Differential Acetone Extraction of Total and Hemoprotein-Unbound Heme to Quantify Heme Binding Capacity of Plasma in Patients with Sickle Cell Disease: The Role of Heme Scavengers

Madhav Vissa, Eric Soupene, PhD, Sandra K. Larkin, MS, Lynne D. Neumayr, MD, Elliott P. Vichinsky, MD, Frans A. Kuypers, PhD

Blood (2020) 136 (Supplement 1): 15.

https://doi.org/10.1182/blood-2020-134717

Published: 2020

Journal Articles

Development of a Severity Score System for Thalassemia Syndromes

Blood (2019) 134 (Supplement_1): 2225.

https://doi.org/10.1182/blood-2019-124675

Published: 2019

Journal Articles

Incidence of Vaso-Occlusive Crisis Does Not Increase with Achieving Higher Hemoglobin Levels on Voxelotor Treatment or after Discontinuation: Analyses of the HOPE Study

Elliott P. Vichinsky, MD, Paul Telfer, DM, FRCP, Adlette Inati, MD, Margaret Tonda, PharmD, Barbara Tong, PhD, Irene Agodoa, MD, Joshua Lehrer-Graiwer, MD MPhil, FACC, Kenneth I. Ataga, MD

Blood (2019) 134 (Supplement_1): 2313.

https://doi.org/10.1182/blood-2019-129026

Published: 2019

Journal Articles

Mitapivat (AG-348), an Oral PK-R Activator, in Adults with Non-Transfusion Dependent Thalassemia: A Phase 2, Open-Label, Multicenter Study in Progress

Kevin H. M. Kuo, MDMSc,FRCPC, D. Mark Layton, MB BS, Katrin Uhlig, MD MS, Megan Lynch, MSN, NP, Li Liu, PhD, Elliott P. Vichinsky, MD

Blood (2019) 134 (Supplement_1): 2249.

https://doi.org/10.1182/blood-2019-123113

Published: 2019

Journal Articles

A Pilot Adult Sickle Cell Hematology Clinic in California's Inland Empire Improves Patient Outcome

Neha Chiruvolu, DO, Amie Patel, DO, Carolyn Rowley, PhD, Marsha J. Treadwell, PhD, Elliott P. Vichinsky, MD, Zahra Pakbaz, MD

Blood (2019) 134 (Supplement_1): 3470.

https://doi.org/10.1182/blood-2019-125160

Published: 2019

Journal Articles

Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent β-Thalassemia in the Northstar (HGB-204) Study

Janet L. Kwiatkowski, MD MSCE, Alexis A. Thompson, MD MPH, John E.J. Rasko, MBBS, PhD, Suradej Hongeng, MD, Gary J. Schiller, MD, Usanarat Anurathapan, MD, Marina Cavazzana, MD PhD, P. Joy Ho, MBBS DPhil FRACP FRCPA, Manfred Schmidt, PhD, Morris Kletzel, MD MBA, Elliott P. Vichinsky, MD, Briana Deary, Ying Chen, PhD, Alexandria Petrusich, Mark C. Walters, MD

Blood (2019) 134 (Supplement_1): 4628.

https://doi.org/10.1182/blood-2019-125807

Published: 2019

Journal Articles

Epidemiologic and Clinical Characteristics of Thalassemia (Thal) Intermedia (TI) in the United States

Elliott P. Vichinsky, MD, Janet Kwiatkowski, MD, Patricia J. Giardina, MD, Carole Paley, MD, Francis Vekeman, MA, Wendy Y. Cheng, MPH, MPhil, Joseph Damron, BA, Nora McCormick, MSc, Medha Sasane, PhDBPharm,MS, Ying Qiu, PhD, Mei Sheng Duh, MPH, ScD, Alexis A. Thompson, MD

Blood (2015) 126 (23): 3279.

https://doi.org/10.1182/blood.V126.23.3279.3279

Published: 2015

Journal Articles

NKTT120 Safely Depletes iNKT Cells in Stable Adult Sickle Cell Patients in a Phase 1 Trial

Joshua J. Field, MD MS, Elaine M. Majerus, MD PhD, Ken I. Ataga, MD, Elliott P. Vichinsky, MD, Cheryl Eaton, Rosemary Mazanet, MD PhD, David G. Nathan, MD

Blood (2015) 126 (23): 2178.

https://doi.org/10.1182/blood.V126.23.2178.2178

Published: 2015

Journal Articles

12-Month Follow-up for Patients with Sickle Cell Disease in an Ongoing 3-Year, Prospective, Non-Interventional Registry Trial

Matthew M. Heeney, MD, Brigitta U. Mueller, MD, Brad Baltz, MD, Patricia Adams-Graves, MD, Elizabeth Yang, MD, PhD, Carole Paley, MD, Jason Esposito, MSHS, Elliott P. Vichinsky, MD

Blood (2012) 120 (21): 1010.

https://doi.org/10.1182/blood.V120.21.1010.1010

Published: 2012

Journal Articles

A Pilot Study of Epigenetic-Differentiation Therapy with Decitabine to Treat β-Thalassemia Intermedia

Nancy F Olivieri, MD, Yogenthiran Saunthararajah, MD, Vivekanandan Thayalasuthan, MD, Janet Kwiatkowski, MD, Russell E. Ware, MD, PhD, Franz Kuypers, PhD, Hae-Young Kim, DrPH, Elliott P Vichinsky, MD

Blood (2010) 116 (21): 2078.

https://doi.org/10.1182/blood.V116.21.2078.2078

Published: 2010

Journal Articles

Safety of Combined Chelation Therapy with Deferasirox and Deferoxamine in Transfusion-Dependent Thalassemia.

Ashutosh Lal, MD, Nancy Sweeters, RN, PNP, Matt Herz, Dru Foote, RN, PNP, Lynne Neumayr, MD, Greg Kurio, MD, Paul R Harmatz, MD, Elliott P Vichinsky, MD

Blood (2009) 114 (22): 2021.

https://doi.org/10.1182/blood.V114.22.2021.2021

Published: 2009

Journal Articles

Pulmonary Hypertension in Thalassemia Assessed by Echocardiography: A Report From Baseline Data of the Thalassemia Clinical Research Network Longitudinal Cohort Study.

Claudia R. Morris, MD, Hae-Young Kim, MS, DrPh, Felicia Trachtenberg, PhD, Charles T. Quinn, MD, MS, Nancy F Olivieri, MD, Nancy Sweeters, RN, PNP, Patricia J Giardina, MD, Janet L Kwiatkowski, MD, MSCE, Alexis A. Thompson, MD, Jeanne Boudreaux, MD, Ellis J Neufeld, MD, PhD, Elliott P Vichinsky, MD

Blood (2009) 114 (22): 2016.

https://doi.org/10.1182/blood.V114.22.2016.2016

Published: 2009

Journal Articles

Chelation Choices and Iron Burden Among Patients with Thalassemia in the 21st Century: a Report From the Thalassemia Clinical Research Network (TCRN) Longitudinal Cohort.

Janet L Kwiatkowski, MD, MSCE, Hae-Young Kim, MS, DrPh, Alexis A. Thompson, Charles T. Quinn, MD, MS, Brigitta U Mueller, Isaac Odame, MBChB, Patricia J Giardina, MD, Elliott P Vichinsky, MD, Jeanne Boudreaux, MD, John B Porter, Thomas Coates, Nancy F Olivieri, MD, Ellis J Neufeld, MD, PhD

Blood (2009) 114 (22): 4056.

https://doi.org/10.1182/blood.V114.22.4056.4056

Published: 2009

Journal Articles

Arginine Therapy for Vaso-Occlusive Pain Episodes in Sickle Cell Disease.

Claudia R. Morris, MD, Michael Ansari, Lisa Lavrisha, RN, PNP, Nancy Sweeters, RN, PNP, Frans A Kuypers, PhD, Elliott P Vichinsky, MD

Blood (2009) 114 (22): 573.

https://doi.org/10.1182/blood.V114.22.573.573

Published: 2009

Journal Articles

Heightened Sulfur Amino Acid Oxidation in Plasma and Erythrocytes in β-Thalassemia Major.

Anurag K. Agrawal, MD, Jung H. Suh, PhD, Bruce N. Ames, PhD, Elliott P. Vichinsky, MD, Ashutosh Lal, MD

Blood (2009) 114 (22): 4065.

https://doi.org/10.1182/blood.V114.22.4065.4065

Published: 2009

Journal Articles

Iron Overload Diminishes the Effectiveness of the Innate Immune Response in Thalassemia Major: a Possible Mechanism for Increased Infection Risk.

Patrick B Walter, PhD, Paul R Harmatz, Annie Higa, B.S., David Killilea, PhD, Nancy Sweeters, RN, PNP, Elliott P Vichinsky, MD

Blood (2009) 114 (22): 4071.

https://doi.org/10.1182/blood.V114.22.4071.4071

Published: 2009

Journal Articles

Oral Arginine Increases Erythrocyte Glutathione Levels in Sickle Cell Disease: Implications for Pulmonary Hypertension.

Claudia R. Morris, MD, Jung Suh, PhD, Elliott P. Vichinsky, MD, Elizabeth S. Klings, MD, Martin H. Steinberg, MD, Mark Shigenaga, PhD, Bruce N. Ames, PhD, Mark T. Gladwin, MD, Gregory J. Kato, MD

Blood (2006) 108 (11): 1208.

https://doi.org/10.1182/blood.V108.11.1208.1208

Published: 2006

Journal Articles

Erythrocyte Glutathione Depletion Is Associated with Severity of Anemia and Pulmonary Hypertension in Patients with Sickle Cell Disease.

Claudia R. Morris, MD, Jung H. Suh, PhD, Sandra Larkin, MS, D. Anton Bland, BS, Adam Odhiambo, BS, Martin H. Steinberg, MD, Elliott P. Vichinsky, MD, Mark Shigenaga, PhD, Bruce Ames, PhD, Frans A. Kuypers, PhD, Elizabeth S. Klings, MD

Blood (2006) 108 (11): 788.

https://doi.org/10.1182/blood.V108.11.788.788

Published: 2006

Journal Articles

Increased Chromosomal Breaks in Sickle Cell Disease as Evidenced by the Presence of Micronuclei in Erythrocytes.

Ashutosh Lal, MD, Amrita Bhagat, Wafa Atamna, BA, Tal Offer, PhD, Elliott P. Vichinsky, MD, Frans A. Kuypers, PhD, Bruce N. Ames, PhD

Blood (2005) 106 (11): 3807.

https://doi.org/10.1182/blood.V106.11.3807.3807

Published: 2005

NARROW

Three Distinct Groups of Phenotype Severity in Beta-Thalassemia

Differential Acetone Extraction of Total and Hemoprotein-Unbound Heme to Quantify Heme Binding Capacity of Plasma in Patients with Sickle Cell Disease: The Role of Heme Scavengers

Development of a Severity Score System for Thalassemia Syndromes

Incidence of Vaso-Occlusive Crisis Does Not Increase with Achieving Higher Hemoglobin Levels on Voxelotor Treatment or after Discontinuation: Analyses of the HOPE Study

Mitapivat (AG-348), an Oral PK-R Activator, in Adults with Non-Transfusion Dependent Thalassemia: A Phase 2, Open-Label, Multicenter Study in Progress

A Pilot Adult Sickle Cell Hematology Clinic in California's Inland Empire Improves Patient Outcome

Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent β-Thalassemia in the Northstar (HGB-204) Study

Epidemiologic and Clinical Characteristics of Thalassemia (Thal) Intermedia (TI) in the United States

NKTT120 Safely Depletes iNKT Cells in Stable Adult Sickle Cell Patients in a Phase 1 Trial

12-Month Follow-up for Patients with Sickle Cell Disease in an Ongoing 3-Year, Prospective, Non-Interventional Registry Trial

A Pilot Study of Epigenetic-Differentiation Therapy with Decitabine to Treat β-Thalassemia Intermedia

Safety of Combined Chelation Therapy with Deferasirox and Deferoxamine in Transfusion-Dependent Thalassemia.

Pulmonary Hypertension in Thalassemia Assessed by Echocardiography: A Report From Baseline Data of the Thalassemia Clinical Research Network Longitudinal Cohort Study.

Chelation Choices and Iron Burden Among Patients with Thalassemia in the 21st Century: a Report From the Thalassemia Clinical Research Network (TCRN) Longitudinal Cohort.

Arginine Therapy for Vaso-Occlusive Pain Episodes in Sickle Cell Disease.

Heightened Sulfur Amino Acid Oxidation in Plasma and Erythrocytes in β-Thalassemia Major.

Iron Overload Diminishes the Effectiveness of the Innate Immune Response in Thalassemia Major: a Possible Mechanism for Increased Infection Risk.

Oral Arginine Increases Erythrocyte Glutathione Levels in Sickle Cell Disease: Implications for Pulmonary Hypertension.

Erythrocyte Glutathione Depletion Is Associated with Severity of Anemia and Pulmonary Hypertension in Patients with Sickle Cell Disease.

Increased Chromosomal Breaks in Sickle Cell Disease as Evidenced by the Presence of Micronuclei in Erythrocytes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only